Comparable stake leader
Vifor (International) Ltd
SEC ownership of ChemoCentryx, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001340652.
Disclosed value leader
Vifor (International) Ltd
Comparable rows
0/3
Latest evidence
07 Jun 2022
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Vifor (International) Ltd
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
07 Jun 2022
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001340652
- Issuer location
- San Carlos, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of ChemoCentryx, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vifor (International) Ltd
Disclosed value leader
Vifor (International) Ltd
Comparable rows
0/3
Latest evidence
07 Jun 2022
3/4/5
Highest disclosed value: $264,636,034
3 rows are not safely comparable across share classes.
Quick read
Vifor (International) Ltd has the largest disclosed position value at $264.64M.
0 of 3 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Vifor (International) Ltd's linked filing trail.
Disclosed position value
Top 2
Vifor (International) Ltd
$264.64M
Henry A. Mckinnell
$3.71M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-3 of 3 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vifor (International) Ltd |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$264,636,034
5,194,085 shares
|
— | 12 Oct 2021 |
| Henry A. Mckinnell |
3/4/5
Director
|
—
class O/S missing
|
$3,706,525
72,749 shares
|
— | 20 May 2022 |
| Yi Ching Yau |
3/4/5
SVP, Finance & Acctg Officer
|
—
class O/S missing
|
—
65,000 shares
|
— | 07 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 24 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-14 of 14 reporting-owner rows connected to ChemoCentryx, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
14
Largest Forms 3/4/5 holder
Vifor (International) Ltd
Net 12M change
$0
Latest report
20 Oct 2022
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Vifor (International) Ltd | 10%+ Owner | $264,636,034 | Mixed | 12 Oct 2021 | ||
| Henry A. Mckinnell | Director | $3,706,525 | Mixed | 20 May 2022 | ||
| Joseph M. Feczko | Director | Mixed | 20 Oct 2022 | |||
| Rita Jain | EVP, Chief Medical Officer, Director | Mixed | 20 Oct 2022 | |||
| David E. Wheadon | Director | Mixed | 20 Oct 2022 | |||
| Susan M. Kanaya | EVP, Chief Financial and Administrative Officer, and Sec., Director | Mixed | 20 Oct 2022 | |||
| James L. Tyree | Director | Mixed | 20 Oct 2022 | |||
| Thomas J. Schall | President and CEO, Director | Mixed | 20 Oct 2022 | |||
| Markus J. Cappel | Chief Bus. Officer & Treasurer | Mixed | 20 Oct 2022 | |||
| Yi Ching Yau | SVP, Finance & Acctg Officer | Mixed | 07 Jun 2022 | |||
| Jennifer Lyn Herron | Director | Mixed | 20 Oct 2022 | |||
| Mr. Geoffrey Parker | Director | Mixed | 20 Oct 2022 | |||
| Tausif Butt | EVP, Chief Operating Officer | Mixed | 20 Oct 2022 | |||
| Thomas A. Edwards | Director | Mixed | 20 Oct 2022 |
Recent insider transactions for ChemoCentryx, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.